| Original language | English |
|---|---|
| Pages (from-to) | 709-710 |
| Number of pages | 2 |
| Journal | The Lancet |
| Volume | 371 |
| Issue number | 9614 |
| Early online date | 28 Feb 2008 |
| DOIs | |
| Publication status | Published - 1 Mar 2008 |
Keywords
- Antineoplastic Combined Chemotherapy Protocols
- Health Status
- Humans
- Interferons
- Melphalan
- Multiple Myeloma
- Prednisone
- Quality of Life
- Questionnaires
- Randomized Controlled Trials as Topic
- Treatment Outcome
Cite this
King, M. T., & Fayers, P. M. (2008). Making quality-of-life results more meaningful for clinicians. The Lancet, 371(9614), 709-710. https://doi.org/10.1016/S0140-6736(08)60324-4
Making quality-of-life results more meaningful for clinicians. / King, Madeleine T; Fayers, Peter M.
In: The Lancet, Vol. 371, No. 9614, 01.03.2008, p. 709-710.Research output: Contribution to journal › Article
King, MT & Fayers, PM 2008, 'Making quality-of-life results more meaningful for clinicians', The Lancet, vol. 371, no. 9614, pp. 709-710. https://doi.org/10.1016/S0140-6736(08)60324-4
King MT, Fayers PM. Making quality-of-life results more meaningful for clinicians. The Lancet. 2008 Mar 1;371(9614):709-710. https://doi.org/10.1016/S0140-6736(08)60324-4
@article{53ca34541eea4c21970d4ed7ce331c2a,
title = "Making quality-of-life results more meaningful for clinicians",
keywords = "Antineoplastic Combined Chemotherapy Protocols, Health Status, Humans, Interferons, Melphalan, Multiple Myeloma, Prednisone, Quality of Life, Questionnaires, Randomized Controlled Trials as Topic, Treatment Outcome",
author = "King, {Madeleine T} and Fayers, {Peter M}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/S0140-6736(08)60324-4",
language = "English",
volume = "371",
pages = "709--710",
journal = "The Lancet",
issn = "0140-6736",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "9614",
}
TY - JOUR
T1 - Making quality-of-life results more meaningful for clinicians
AU - King, Madeleine T
AU - Fayers, Peter M
PY - 2008/3/1
Y1 - 2008/3/1
KW - Antineoplastic Combined Chemotherapy Protocols
KW - Health Status
KW - Humans
KW - Interferons
KW - Melphalan
KW - Multiple Myeloma
KW - Prednisone
KW - Quality of Life
KW - Questionnaires
KW - Randomized Controlled Trials as Topic
KW - Treatment Outcome
U2 - 10.1016/S0140-6736(08)60324-4
DO - 10.1016/S0140-6736(08)60324-4
M3 - Article
C2 - 18313491
VL - 371
SP - 709
EP - 710
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 9614
ER -